InMed Pharmaceuticals Inc. — Director's Dealing 2021

Oct 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InMed Pharmaceuticals Inc. (INM)
CIK: 0001728328
Period of Report: 2021-10-18

Reporting Person: MANCINI ALEXANDRA DIANE JANET (Sr VP, Clinical Reg Affairs)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-18	Employee Stock Option (Right to Buy)	$1.40	A	35000	Acquired	2026-10-17	Common shares (35000)	Direct

Footnotes

F1: The options were granted on 10/18/2021 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.